A Clinical trial to study the effect of the drug Perungaya Chooranam in patients having Diabetes Mellitus (Madhumegam)

An open Non-randomized clinical trial of Perungaya Chooranam in Madhumegam(Diabetes Mellitus- Type II )

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012505

Enrollment

Registered

2018-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MALE AND FEMALE WITH POLYURIA,POLYDYPSIA,BURNING SENSATION AND NUMBNESS OVER THE FOOT AND PALM

Interventions

Intervention1: PERUNGAYA CHOORANAM : 2 grams of Perungaya chooranam is administrated twice a day with luke warm water for 90 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Newly identified type II cases only Subject within 30-60 years Blood glucose(F)- 120-140mg/dl Blood glucose(PP)-180-280mg/dl Blood glucose(R)-200-300mg/dl HbA1C - 6.5 TO 8% Polyuria Polyphagia Polydypsia Nocturia Fatigue

Exclusion criteria

Exclusion criteria: H/O Insulin Dependent Diabetes Mellitus H/O Cardiovascular Disease H/O Diabetic Nephropathy H/O Diabetic Retinopathy Pregnant Women, Lactating mothers,T.B affected individuals

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduced blood sugar and HbA1C Level and reduced in clinical symptomsTimepoint: 90 Days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 90 DAYS	—

Countries

India

Contacts

Public ContactDr Nithya K

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026